On Monday, Indian food safety watchdog the Food Safety and Standards Authority of India (FSSAI) announced that health supplements cannot be sold as medicines at all and also fixed the permissible limits of various ingredients used in the products. New standards have been issued for manufacturers of the products to check mislabelling.

The Food Safety and Standards Authority of India has operationalised with immediate effect new standards for 8 categories of products including health supplements and nutraceuticals.

CEO Pawan Aggarwal said “Last year, we had issued draft standards on health supplements, nutraceuticals, food for special dietary use, food for special medical purpose, functional food and novel food. We have finalized this and operationalised with immediate effect,”

The Food Safety and Standards Authority of India (FSSAI) will now start granting licences and approve products manufactured based on the new standards. However, these regulations will be enforced from January 2018. “Considering that the regulation is final, FSSAI has made the regulations operational with immediate effect in order to facilitate food business,” the regulator said in a statement.

The new rules comprises of the following,

  • Every package of health supplement should carry the words ‘health supplement’ as well as an advisory warning ‘not for medicinal use’ prominently written.
  • “The quantity of nutrients added to the articles of food shall not exceed the recommended daily allowance as specified by the Indian Council of Medical Research and in case such standards are not specified, standards laid down by the international food standards body namely Codex Alimentarius Commission shall apply,”
  • Health supplements may be used to supplement the normal diet of anyone above the age of 5 years.
  • Labelling and packaging norms have been prescribed for nutraceuticals, food for special dietary use, food for special medical purpose, functional and novel food.

Confederation of Indian Industry (CII) said the regulation will help greatly in resolving the issues challenges this sector and creating a conducive regulatory environment for the industry to operate.

PROGRESSIVE GROCER INDIA

Other News

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More

TGA Supports MHRA’s New Regulations

The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]

Read More

Medical Devices with Extended CE Certification Are Now Accepted On The UK Market

The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]

Read More

The NMPA Enhanced Regulation of Cosmetic Medicine

According to a representative of the State Administration for Market Regulation, after the industry’s quick development, prominent issues like unethical medical practices, fake goods, false advertising, and price fraud emerged, endangering the health and interests […]

Read More

Radiation Sterilization Master File Pilot Program Announced by CDRH

CDRH is establishing a Radiation Sterilization Master File Pilot Program to assist businesses in developing less troublesome regulatory methods for sterilizing licensed medical equipment, such as switching radiation sources. The pilot program, which is optional, […]

Read More